Bristol, United Kingdom

Colin W Pouton

This inventor holds 2 USPTO granted patents. Top assignee: Sterling Winthrop Inc.. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Colin W Pouton. Retrieved from https://idiyas.com/inventor/colin-w-pouton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Colin W Pouton: Innovator in Biologically Compatible Polymers

Introduction

Colin W Pouton is a notable inventor based in Bristol, GB. He has made significant contributions to the field of polymer science, particularly in the development of biologically compatible linear block copolymers. His work has implications for drug delivery and imaging agents, showcasing the intersection of chemistry and medicine.

Latest Patents

Colin W Pouton holds 2 patents that focus on biologically compatible linear block copolymers of polyalkylene oxide. His latest patents describe a linear block copolymer comprising units of an alkylene oxide, linked to units of peptide via a linking group. This innovative structure is useful as an imaging agent, drug, prodrug, or as a delivery system for imaging agents, drugs, or prodrugs.

Career Highlights

Colin has been associated with Sterling Winthrop Inc., where he has contributed to various research initiatives. His expertise in polymer chemistry has positioned him as a key figure in the development of new materials that enhance drug delivery systems.

Collaborations

Colin has worked alongside notable colleagues such as Eugene Rex Cooper and Stephen P Jones. Their collaborative efforts have further advanced the research in the field of biologically compatible materials.

Conclusion

Colin W Pouton is a distinguished inventor whose work in polymer science continues to impact the medical field. His innovative patents and collaborations highlight his commitment to advancing drug delivery technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…